Hap Trading, LLC Bria Cell Therapeutics Corp. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$3.0 - $8.31 $90,600 - $250,962	30,200 Added 178.7%	47,100 $12,000
Q2 2022 Aug 12, 2022	BUY	$4.28 - $11.9 $3,424 - $9,520	800 Added 4.97%	16,900 $4,000
Q1 2022 May 12, 2022	SELL	$5.91 - $10.14 $63,828 - $109,512	-10,800 Reduced 40.15%	16,100 $19,000
Q4 2021 Feb 14, 2022	BUY	$7.1 - $10.61 $190,990 - $285,409	26,900 New	26,900 $16,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $9.31M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.